关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  7 0 0 8 1 6 9 位浏览者
您当前的位置:首页 >> 正文

HPLC法测定不同来源米非司酮胶囊的有关物质

HPLC determination of related substances in mifepristone capsules from different soures

分类号:
出版年·卷·期(页码):2014,34 (3):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:建立米非司酮胶囊有关物质测定的HPLC法,对其主要有关物质进行研究,制定有关物质合理限度,有效控制产品质量。方法:采用RP-HPLC法,色谱柱为C18柱,流动相:乙腈-10 mmol·L-1磷酸二氢钾溶液(用磷酸调节pH至2.5)(35:65),流速1.0 mL·min-1,检测波长304 nm,柱温35 ℃。结果:米非司酮胶囊中的主要杂质为N-单去甲基米非司酮,既是副产物也是降解产物。A企业3批样品中该杂质含量均为0.5%,B企业3批样品中该杂质含量均为0.2%。A企业3批样品杂质总量为0.6%~0.7%,B企业3批样品杂质总量为0.2%~0.3%。结论:本方法可快速有效分离米非司酮胶囊中各有关物质。对已知、未知有关物质分别设定不同限度,可有效控制该药品质量。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To establish an HPLC method for the determination of related substances in mifepristone capsules,and to study its principal related substances and set reasonable limits for related substances to improve the quality control for mifepristone capsules. Methods: Related substances were analyzed by the RP-HPLC method.The C18 column was used and a mixture of acetonitrile and phosphate BS(10 mmol·L-1 potassium dihydrogen phosphate,adjusted to pH 2.5 with phosphoric acid)(35:65) was used as the mobile phase.The flow rate was 1.0 mL· min-1,and the detection wavelength was 304 nm,and the column temperature was 35 ℃. Results: The main impurity was N-mono-demethylated mifepristone,which was both a by-product and a degradation product.The content of this impurity in 3 batches of manufacturer A was 0.5%,and that in 3 batches of manufacturer B was 0.2%.The total content of impurities in 3 batches of manufacturer A was 0.6%-0.7%,and in 3 batches of manufacturer B was 0.2%-0.3%. Conclusion: Mifepristone and its related substances were obviously separated under the chromatographic system described above.The limit for N-mono-demethylated mifepristone was 1.0% and the limit for other individual impurities was 0.2% and the limit for total impurities was 1.5%.This method can control the quality of mifepristone capsules effectively.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 915位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn

本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:010-60213898